CELL INTELLIGENCE · 肿瘤细胞治疗研究

在黑色素瘤中探索免疫检查点抑制剂和新型免疫疗法的前景：长期结局、进展与挑战

Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges.

“再多一次生存机会”：晚期黑色素瘤患者及其伴侣接受 TIL（肿瘤浸润淋巴细胞）治疗的体验——一项定性研究及对未来照护的建议

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a quali

临床数据支持 TIL 疗法在晚期黑色素瘤治疗中的作用。